NYSE - Nasdaq Real Time Price USD
Solventum Corporation (SOLV)
75.43 +0.87 (+1.17%)
As of June 18 at 4:00:03 PM EDT. Market Open.
Trade SOLV on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for SOLV
- Previous Close
74.56 - Open
75.24 - Bid 75.55 x 20000
- Ask 75.20 x 90000
- Day's Range
74.18 - 75.77 - 52 Week Range
62.38 - 88.20 - Volume
1,040,123 - Avg. Volume
1,726,784 - Market Cap (intraday)
13.063B - Beta (5Y Monthly) 0.75
- PE Ratio (TTM)
9.23 - EPS (TTM)
8.17 - Earnings Date May 5, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
82.15
Recent News
View More
Performance Overview
Trailing total returns as of 6/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
SOLV
4.81%
S&P 500 (^GSPC)
9.57%
1-Year Return
SOLV
3.86%
S&P 500 (^GSPC)
25.41%
3-Year Return
SOLV
17.16%
S&P 500 (^GSPC)
70.10%
5-Year Return
SOLV
17.16%
S&P 500 (^GSPC)
80.02%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/18/2026
Market Cap
13.06B
Enterprise Value
17.79B
Trailing P/E
9.23
Forward P/E
11.51
PEG Ratio (5yr expected)
1.22
Price/Sales (ttm)
1.60
Price/Book (mrq)
2.63
Enterprise Value/Revenue
2.15
Enterprise Value/EBITDA
7.14
Financial Highlights
Profitability and Income Statement
Profit Margin
17.33%
Return on Assets (ttm)
2.75%
Return on Equity (ttm)
34.79%
Revenue (ttm)
8.26B
Net Income Avi to Common (ttm)
1.43B
Diluted EPS (ttm)
8.17
Balance Sheet and Cash Flow
Total Cash (mrq)
561M
Total Debt/Equity (mrq)
106.46%
Levered Free Cash Flow (ttm)
378.5M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
143.98
+1.67%
Mkt Cap 39.672B
Industry Medical Instruments & Supplies
327.95
+1.35%
Mkt Cap 23.169B
Industry Medical Instruments & Supplies
Mkt Cap undefined -
Industry -
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View MoreSolventum Earnings: Mixed Quarterly Results Buffeted by Changing Portfolio and Tariffs
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
RatingPrice TargetSolventum Earnings: Mixed Quarterly Results Buffeted by Changing Portfolio and Tariffs
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
RatingPrice TargetStocks are higher at midday on Friday, with a healthy newsflow that includes
Stocks are higher at midday on Friday, with a healthy newsflow that includes earnings reports, a non-farm payrolls report that significantly beat expectations, and an update on consumer sentiment that showed consumers are feeling pain at the pump. Indeed, the University of Michigan's survey was at the lowest level on record.
Transforming for growth
Solventum is a healthcare company that develops, manufactures, and commercializes a range of solutions. The company was spun out of 3M in April 2024. Solventum's MedSurg segment provides advanced wound care and surgical solutions. Dental Solutions is a provider of a comprehensive suite of restorative, preventive, and orthodontic solutions for dentists and orthodontists. The Health Information Systems (HIS) segment provides software solutions powered by clinical intelligence that create time for clinicians to care for patients and improve accuracy in healthcare reimbursement. Target customer markets include public and private hospitals, physician groups, and clinics, federal government agencies, and payer organizations. SOLV is a component of the S&P 500.
RatingPrice Target